Outcomes of Steroid-Avoidance Protocols in Pediatric Kidney Transplant Recipients

Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH Division of Nephrology, St. Louis University at Cardinal Glennon Children's Medical Center, St. Louis, MO.
American Journal of Transplantation (Impact Factor: 5.68). 09/2012; 12(12). DOI: 10.1111/j.1600-6143.2012.04278.x
Source: PubMed


Advances in immunosuppression have facilitated increased use of steroid-avoidance protocols in pediatric kidney transplantation. To evaluate such steroid avoidance, a retrospective cohort analysis of pediatric kidney transplant recipients between 2002 and 2009 in the United Network for Organ Sharing database was performed. Outcomes (acute rejection and graft loss) in steroid-based and steroid-avoidance protocols were assessed in 4627 children who received tacrolimus and mycophenolate immunosuppression and did not have multiorgan transplants. Compared to steroid-based protocols, steroid avoidance was associated with decreased risk of acute rejection at 6 months posttransplant (8.3% vs. 10.9%, p = 0.02) and improved 5-year graft survival (84% vs. 78%, p < 0.001). However, patients not receiving steroids experienced less delayed graft function (p = 0.01) and pretransplant dialysis, were less likely to be African-American and more frequently received a first transplant from a living donor (all p < 0.001). In multivariate analysis, steroid avoidance trended toward decreased acute rejection at 6 months, but this no longer reached statistical significance, and there was no association of steroid avoidance with graft loss. We conclude that, in clinical practice, steroid avoidance appears safe with regard to graft rejection and loss in pediatric kidney transplant recipients at lower immunologic risk.

Download full-text


Available from: Jens Goebel, Dec 22, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Over the last decade, steroid minimization became one of the major goals in pediatric renal transplantation. Different protocols have been used by individual centers and multicenter study groups, including early and late steroid withdrawal or even complete avoidance. The timing of steroid withdrawal determines if antibodies are used, as avoidance and early withdrawal require antibody induction, while late withdrawal typically does not. A monoclonal antibody was used in most protocols during an early steroid withdrawal together with tacrolimus and mycophenolate mofetil in low immunological risk patients. Polyclonal induction was reported as effective in high-risk patients. Cyclosporine A and mycophenolate mofetil were used in late steroid withdrawal with no induction. All described protocols were effective in terms of preventing acute rejection and preserving renal graft function. There was no superiority of any specific protocol in terms of clinical benefits of steroid withdrawal. Pre-puberty determined growth benefit while other clinical advantages, including better control of glycemia, lipids, and blood pressure, were age independent. It is not clear whether the steroid withdrawal increases the risk of recurrence of primary glomerular diseases post-transplant, however it cannot be excluded. There is no evidence to date for a higher risk of anti-HLA production in steroid-free children after renal transplantation. Key summary points - Current strategies to minimize the steroid-related adverse effects in pediatric renal graft recipients include steroid withdrawal, early or late after transplantation, or complete steroid avoidance - Early steroid withdrawal or avoidance is generally used following the induction therapy with mono- or polyclonal antibodies, while in late steroid withdrawal induction therapy was generally not used - Elimination of steroids (early or late) does not increase the risk of acute rejection and does not deteriorate long-term renal graft function - Early steroid withdrawal is possible in patients at high immunological risk using a combination of polyclonal antibody induction, tacrolimus, and mycophenolate mofetil - All protocols of steroid minimization showed relevant clinical benefits, however the growth-related benefit was limited to pre-pubertal patients in all but one of the studies - Adverse events of steroid withdrawal occurred in a higher incidence of post-transplant bone marrow suppression Key research points - There is no clear evidence of the impact of steroid withdrawal on the risk of recurrence of primary glomerulonephritis after renal transplantation in children, therefore further evaluation of this important issue should be performed in prospective trials - There is limited pediatric data on the risk of anti-HLA/donor-specific antibody production in steroid-free patients after renal transplantation. It is not clear whether the selection of the type of induction antibody (lymphocyte depleting versus short, two-dose administration of anti-IL2R inhibitor) is important in this term. The production of anti-HLA antibodies should then be monitored on a regular basis and analyzed in prospective trials.
    No preview · Article · Jan 2013 · Pediatric Nephrology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The outcome of pediatric kidney transplantation depends on several factors, among these are the complications, which occur in relation to the surgical procedure. In this study, we present our experience with pediatric kidney transplantation in a steroid-free immunosuppression regimen, from a surgical point of view. Patient charts of pediatric kidney transplantations in the period 1998-2011 were reviewed. Surgical complications, acute rejection, and patient and graft survivals were recorded. Sixty-one renal transplantations were performed in 58 patients. Thirty patients (49.1%) experienced a surgical complication, of which 11 (18%) required an explorative laparotomy. Overall the five-year Kaplan-Meier patient survival rate was 96.2% and the graft survival rate was 88.6%. Nine patients (14.7%) had an acute rejection episode within the first year after transplantation. No correlation was observed between surgical complications and acute rejection episodes or graft loss. This study indicated a high incidence of surgical complications among pediatric kidney transplantations when using a steroid-free immunosuppression regimen. Despite this, we observed high overall patient and graft survival, supporting the trend toward steroids avoidance in pediatric kidney transplantation.
    Preview · Article · Nov 2013 · Transplantation Proceedings
  • [Show abstract] [Hide abstract]
    ABSTRACT: Kidney transplantation is the treatment of choice for end-stage renal disease (ESRD) in children. Although long-term survival on dialysis has improved over the past three decades, survival remains better for children who undergo kidney transplantation. Children undergoing kidney transplantation frequently require post-operative care in the Pediatric Intensive Care Unit (PICU). For example, it is frequently necessary to infuse large volumes of fluid, plasma, and blood to prevent hypovolemia, acute tubular necrosis, and venous thrombosis of the renal allograft. These problems are compounded when a relatively young child receives an adult allograft. Because a large volume of blood is shifted to the renal allograft, the recipient's heart will have to work harder to circulate a relatively higher cardiac output (CO) to the adult-sized renal allograft. Post-operative fluid management and hemodynamic monitoring is therefore of crucial importance. Finally, there are several potential complications in the early and late post-operative period that are relevant to the pediatric critical care physician.
    No preview · Article · Jan 2014 · Pediatric Critical Care Medicine
Show more